ExodusPoint Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36M Buy
+28,318
New +$2.24M 0.02% 724
2025
Q3
Sell
-100,997
Closed -$4.41M 1806
2025
Q2
$4.41M Buy
100,997
+71,496
+242% +$2.46M 0.05% 461
2025
Q1
$807K Buy
29,501
+15,375
+109% +$560K 0.01% 973
2024
Q4
$568K Buy
+14,126
New +$638K 0.01% 1121
2023
Q4
Sell
-11,217
Closed -$156K 1786
2023
Q3
$156K Sell
11,217
-174,308
-94% -$3.5M ﹤0.01% 1560
2023
Q2
$4.26M Buy
+185,525
New +$5.32M 0.05% 510
2022
Q4
Sell
-21,552
Closed -$469K 1903
2022
Q3
$469K Buy
+21,552
New +$568K 0.01% 1389
2020
Q4
Sell
-15,969
Closed -$516K 2192
2020
Q3
$516K Buy
+15,969
New +$487K 0.02% 995

Other funds holding KYMR